Teyi Pharmaceutical Group (002728.SZ) has accumulated a repurchase of 2.48% of shares, costing 93.9418 million yuan.
Te Yi Pharmaceutical (002728.SZ) announced that as of February 28, 2025, the company will be traded through centralized bidding...
Teyi Pharmaceutical Group (002728.SZ) announced that as of February 28, 2025, the company repurchased 12.7296 million shares of its own stock through centralized bidding, representing 2.48% of the company's current total share capital. The total amount paid was RMB 93.9418 million (excluding related transaction costs).
Related Articles
Deleveraging, focusing on cash flow, CIMC Real Estate recovers 2.534 billion.
Farasis Energy (Gan Zhou) Co., Ltd. (688567.SH): Shenzhen Anyan plans to reduce its shareholding by no more than 2%.
Donghai Securities: Public Offering Fee Reform Implemented in Three Phases, Differentiated Arrangements Continuously Optimizing the Industry Ecology.
Deleveraging, focusing on cash flow, CIMC Real Estate recovers 2.534 billion.
Farasis Energy (Gan Zhou) Co., Ltd. (688567.SH): Shenzhen Anyan plans to reduce its shareholding by no more than 2%.
Donghai Securities: Public Offering Fee Reform Implemented in Three Phases, Differentiated Arrangements Continuously Optimizing the Industry Ecology.
RECOMMEND
Bank Of America Sees Three Drivers Supporting Chinese Consumer Stocks: Low Base, Deep Undervaluation, And Convertible‑Like Defensive Traits
07/01/2026
Cross‑Border E‑Commerce In 2025: Tariffs, Trade Wars, And Shifting Away From The United States
07/01/2026
Asian Stock Markets Record The Strongest Annual Start Ever As Shanghai Composite Hits Multi‑Year High And Sets Longest Winning Streak; Japan And Korea Rally
07/01/2026
